Brazil Drug Industry Frets Pricing Formula Delay Could Cause Problems
This article was originally published in PharmAsia News
Executive Summary
Drug makers in Brazil are raising concerns about the government's uncharacteristic delay in publishing how it has calculated new price caps for medicines sold in the country.
Drug makers in Brazil are raising concerns about the government's uncharacteristic delay in publishing how it has calculated new price caps for medicines sold in the country. The delay, the first in nine years of holding to a schedule, could mean the government is trying to raise them artificially, in a way the industry would consider harmful, said the head of the Sao Paulo industry group Sindusfarma. The formula normally would have been published last September and without it, companies are unable to plan their strategies for this year, he said. (Click here for more
)
"Drug Makers Wary Brazil Price Index For Medicine To Crimp Revenue" - Bloomberg (U.S.) (1/20/2014)